Recall: D-0084-2024

Class II - Potentially Harmful

Class IIClassification

2023-10-20Initiated

TerminatedStatus

SUN PHARMACEUTICAL INDUSTRIES Firm

Product

Liothyronine Sodium Tablets, USP, 25 mcg, 100-count bottles, Rx only, Distributed by: Sun Pharmaceutical Industries, Inc.Cranbury, NJ 08512, Manufactured by: Sun Pharmaceutical Industries Ltd. Survey No. 259/15, Dadra-396 191,(U.T. of D & NH), India. NDC 62756-590-88

Reason

Failed Impurities/Degradation Specifications.

Distribution

Nationwide within the United States

Source: FDA drug enforcement report via openFDA (Voluntary: Firm initiated). If you take this product, talk to your pharmacist or doctor before stopping it.